文献速递传染病防控与疫情报告免疫规划

SARS-CoV-2快速诊断检测使用差异对疫苗有效性估计的偏倚影响

Differences in SARS-CoV-2 rapid diagnostic testing usage by COVID-19 vaccination status can bias vaccine effectiveness estimates against symptomatic SARS-CoV-2 infection from a test-negative design.
PubMed 文献 · Int J Epidemiol · 2026-01-01

该研究利用美国COVID-19监测数据进行个体水平模拟,评估快速诊断检测(RDT)使用和就医概率因疫苗接种状态不同而对检测阴性设计(TND)疫苗有效性(VE)估计的偏倚。结果显示,根据RDT使用差异,VE可被低估(如-5.8至-6.1个百分点)或高估(如5.2至8.4个百分点)。

要点

  • 疫苗接种状态间RDT使用差异可导致TND的VE估计偏倚。
  • 偏倚方向取决于就医概率与RDT结果的交互。
  • 解读TND的VE估计时需考虑RDT使用差异。

核心结论

  • TND对症状性SARS-CoV-2感染的VE估计可能被低估或高估,取决于疫苗接种组间RDT使用差异。

主要发现

  • 当接种者阳性RDT后就医概率高于未接种者时,VE被低估-5.8个百分点(95% UI: -9.1, -2.4)。
  • 当未接种者阴性RDT后就医概率高于接种者时,VE被低估-6.1个百分点(UI: -9.9, -2.5)。
  • 当接种者阴性RDT后就医概率高于未接种者时,VE被高估5.2个百分点(UI: 2.4, 7.7)。
  • 当未接种者阳性RDT后就医概率高于接种者时,VE被高估8.4个百分点(UI: 5.6, 11.3)。

临床怎么用

  • 在解读TND的VE估计时,应评估疫苗接种状态间RDT使用差异的可能影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of rapid diagnostic tests (RDTs) may bias vaccine effectiveness (VE) estimates from test-negative design (TND) studies. We conducted individual-level simulations using national, US COVID-19 surveillance data to assess potential bias at varying likelihoods of visiting a healthcare facility and prevalence of RDT use. METHODS: Twenty-one scenarios that varied the probabilities of visiting a healthcare facility and RDT use by vaccination status were simulated. VE was calculated as 100 × (1 - odds ratio), comparing the odds of symptomatic SARS-CoV-2 infection between vaccinated and unvaccinated groups of people. VE estimates were compared to VE estimates from simulations without RDT testing to calculate the bias in percentage points (pp). RESULTS: VE was underestimated when either vaccinated people were more likely (probability of .5) than unvaccinated people (probability of .3) to visit a healthcare facility after a positive RDT [-5.8%age points (pp); 95% uncertainty interval (UI): -9.1, -2.4] or unvaccinated people were more likely than vaccinated people to visit a healthcare facility after a negative RDT (bias = -6.1 pp; UI: -9.9, -2.5). Conversely, VE was overestimated when either vaccinated people were more likely than unvaccinated people to visit a healthcare facility after a negative RDT (bias = 5.2; UI: 2.4, 7.7) or unvaccinated people were more likely than vaccinated people to visit a healthcare facility after a positive RDT (bias = 8.4 pp; UI: 5.6, 11.3). CONCLUSION: VE estimates against symptomatic SARS-CoV-2 infection from a TND may be under- or overestimated, depending on differences in RDT usage between vaccination groups.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Wiegand RE, Derado G, Ciesla AA, et al. Differences in SARS-CoV-2 rapid diagnostic testing usage by COVID-19 vaccination status can bias vaccine effectiveness estimates against symptomatic SARS-CoV-2 infection from a test-negative design. Int J Epidemiol. 2026. PMID: 42909463. doi:10.1093/ije/dyag226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。